The aim of this study was to develop a dual receptor targeting peptide heterodimer probe, which can target CXCR4 and integrin αvβ3 simultaneously, to improve the detection sensitivity of tumors, especially PC. Here, CXCR4 is linked to pachyonychia congenita.